rs3211719

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000504.4(F10):​c.70+270A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.213 in 152,112 control chromosomes in the GnomAD database, including 3,657 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.21 ( 3657 hom., cov: 32)

Consequence

F10
NM_000504.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.427

Publications

13 publications found
Variant links:
Genes affected
F10 (HGNC:3528): (coagulation factor X) This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]
F10 Gene-Disease associations (from GenCC):
  • congenital factor X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 13-113123195-A-G is Benign according to our data. Variant chr13-113123195-A-G is described in ClinVar as Benign. ClinVar VariationId is 1249655.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.292 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000504.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F10
NM_000504.4
MANE Select
c.70+270A>G
intron
N/ANP_000495.1
F10
NM_001312674.2
c.70+270A>G
intron
N/ANP_001299603.1
F10
NM_001312675.2
c.70+270A>G
intron
N/ANP_001299604.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F10
ENST00000375559.8
TSL:1 MANE Select
c.70+270A>G
intron
N/AENSP00000364709.3
F10
ENST00000375551.7
TSL:1
c.70+270A>G
intron
N/AENSP00000364701.3
F10
ENST00000410083.6
TSL:1
n.70+270A>G
intron
N/AENSP00000386320.2

Frequencies

GnomAD3 genomes
AF:
0.213
AC:
32313
AN:
151994
Hom.:
3651
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.307
Gnomad AMR
AF:
0.165
Gnomad ASJ
AF:
0.239
Gnomad EAS
AF:
0.305
Gnomad SAS
AF:
0.169
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.247
Gnomad OTH
AF:
0.198
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.213
AC:
32348
AN:
152112
Hom.:
3657
Cov.:
32
AF XY:
0.210
AC XY:
15589
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.170
AC:
7060
AN:
41490
American (AMR)
AF:
0.165
AC:
2526
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.239
AC:
829
AN:
3472
East Asian (EAS)
AF:
0.304
AC:
1570
AN:
5162
South Asian (SAS)
AF:
0.168
AC:
810
AN:
4826
European-Finnish (FIN)
AF:
0.188
AC:
1989
AN:
10592
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.247
AC:
16809
AN:
67972
Other (OTH)
AF:
0.198
AC:
418
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1301
2602
3903
5204
6505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.233
Hom.:
6873
Bravo
AF:
0.209
Asia WGS
AF:
0.230
AC:
798
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.2
DANN
Benign
0.65
PhyloP100
-0.43
PromoterAI
0.11
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3211719; hg19: chr13-113777509; API